Dalia Rotstein

Dr. Rotstein specializes in multiple sclerosis and other demyelinating diseases. She works at the Barlo MS Centre where she supervises residents and fellows, and also participates in general neurology and ward service. Her research is focused on the epidemiology of demyelinating diseases. She is recognized as a leading expert on neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody disease (MOGAD) in Canada, and is the principal investigator for CANOPTICS, a national multi-centre cohort study investigating characteristics and treatment of these diseases in Canada.